In the BioHarmony Drug Report Database
Dolasetron
Anzemet (dolasetron) is a small molecule pharmaceutical. Dolasetron was first approved as Anzemet on 1997-09-11. It is used to treat postoperative nausea and vomiting in the USA.
Trade Name
|
Anzemet |
|---|---|
Common Name
|
dolasetron |
ChEMBL ID
|
CHEMBL2368925 |
Indication
|
postoperative nausea and vomiting |
Drug Class
|
Serotonin 5-HT3 antagonists |
Image (chem structure or protein)